AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32492712 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 400
Study 32492712 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer >2,500 ng/mL
Number of subjects: 400
Study 34059401 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate 150–600 mg daily
Number of subjects: 77
Study 34059401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 34787248 — intervention group
Group type: EXPERIMENTAL
Intervention: 35%‐hydrogen peroxide (HP)
Number of subjects: 15
Study 34787248 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet light (VL)
Number of subjects: 15
Study 34787248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (OZ)
Number of subjects: 15
Study 34787248 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet light with hydrogen peroxide (VL+HP)
Number of subjects: 15
Study 34787248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone with hydrogen peroxide (OZ+HP)
Number of subjects: 15
Study 34787248 — intervention group
Group type: COMPARATOR
Intervention: Violet light (VL) and Ozone (OZ) used alone
Number of subjects: 15
Study 33555982 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed loop (HCL) system (Medtronic 670G™)
Number of subjects: 17
Study 33555982 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin pump therapy
Number of subjects: 17
Study 36049047 — intervention group
Group type: EXPERIMENTAL
Intervention: nCaF2‐primer
Number of subjects: 31
Study 36049047 — intervention group
Group type: COMPARATOR
Intervention: Control primer (Transbond)
Number of subjects: 31
Study 34438354 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2000 mg/day
Number of subjects: 60
Study 34438354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32568198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) plus transcranial direct current stimulation (tDCS)
Number of subjects: 375
Study 32568198 — intervention group
Group type: COMPARATOR
Intervention: Sham cognitive remediation (sham-CR) plus sham transcranial direct current stimulation (sham-tDCS)
Number of subjects: 375
Study 36173561 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 57
Study 36173561 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 57
Study 34212474 — intervention group
Group type: EXPERIMENTAL
Intervention: SNT+RUTF
Number of subjects: 260
Study 34212474 — intervention group
Group type: COMPARATOR
Intervention: SNT
Number of subjects: 260
Study 32595523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Contraceptive (OC)
Number of subjects: 47
Study 32595523 — intervention group
Group type: COMPARATOR
Intervention: Natural Menstrual Cycles (MC)
Number of subjects: 47
Study 36476332 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical group
Number of subjects: 144
Study 36476332 — intervention group
Group type: COMPARATOR
Intervention: Nipple group
Number of subjects: 144
Study 36476332 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 144
Study 33303455 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe Maternal Morbidity (SMM)
Number of subjects: 638
Study 33303455 — intervention group
Group type: EXPERIMENTAL
Intervention: Children from SMM group
Number of subjects: 638
Study 33303455 — intervention group
Group type: COMPARATOR
Intervention: Control group (without SMM)
Number of subjects: 638
Study 33303455 — intervention group
Group type: EXPERIMENTAL
Intervention: SMM group
Number of subjects: 638
Study 36473477 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (received video of PCNL procedure)
Number of subjects: 109
Study 36473477 — intervention group
Group type: COMPARATOR
Intervention: No-video group (received only written and verbal information)
Number of subjects: 109
Study 33559438 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at 5-6 local acupoints and 3-4 distal acupoints, retained for 30 min, three times a week for 8 weeks.
Number of subjects: 42
Study 33559438 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture treatment with shallow needling technique at non-acupoint, retained for 30 min, three times a week for 8 weeks.
Number of subjects: 42
Study 32459651 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based diabetes prevention program (DPP) with step-dependent feedback messages and SMS texts over 12 months.
Number of subjects: 200
Study 32459651 — intervention group
Group type: COMPARATOR
Intervention: Standard web-based DPP without SMS texts (control group).
Number of subjects: 200
Study 35998021 — intervention group
Group type: EXPERIMENTAL
Intervention: GoalKeeper (GK), an internet-based system for eliciting and monitoring family-centered goals for CMC, used during an initial clinic visit and for 3 months after.
Number of subjects: 46
Study 35998021 — intervention group
Group type: EXPERIMENTAL
Intervention: GoalKeeper (GK)
Number of subjects: 46
Study 34172261 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume suction with an aerosol cannula (Group B)
Number of subjects: 24
Study 34172261 — intervention group
Group type: COMPARATOR
Intervention: Medium-volume suction (Group A)
Number of subjects: 24
Study 33632282 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist-based educational program (once)
Number of subjects: 84
Study 33632282 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist-based educational program (twice)
Number of subjects: 84
Study 33632282 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 84
Study 34983144 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus azithromycin (Group B)
Number of subjects: 102
Study 34983144 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin alone (Group A)
Number of subjects: 102
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment for acute ischemic stroke
Number of subjects: 1988
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Collateral status on baseline computed tomography angiography
Number of subjects: 1988
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1988
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 1988
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose level
Number of subjects: 1988
Study 32279619 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusion of the intracranial segment of the internal carotid artery with occlusion of the terminus
Number of subjects: 1988
Study 34916068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (n = 106) for 8 weeks
Number of subjects: 222
Study 34916068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 116) for 8 weeks
Number of subjects: 222
Study 34916068 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (n = 37) for 8 weeks after sertraline nonresponse
Number of subjects: 222
Study 32664244 — intervention group
Group type: EXPERIMENTAL
Intervention: PATCH self-assessment
Number of subjects: 52
Study 32664244 — intervention group
Group type: COMPARATOR
Intervention: Standard care nurse-led assessment
Number of subjects: 52
Study 35579104 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral care tablet containing kiwifruit powder (intervention II)
Number of subjects: 32
Study 35579104 — intervention group
Group type: COMPARATOR
Intervention: Tongue brushing (intervention I)
Number of subjects: 32
Study 37562904 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg tablet
Number of subjects: 38
Study 37562904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 34409964 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based, 6-month controlled lifestyle intervention focusing on plant-based diet, physical activity, stress management, and improved social life
Number of subjects: 201
Study 34409964 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study 32925629 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor at 39 weeks
Number of subjects: 7112
Study 32925629 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 7112
Study 32925629 — intervention group
Group type: COMPARATOR
Intervention: Not participating in research
Number of subjects: 7112
Study 32925629 — intervention group
Group type: COMPARATOR
Intervention: Declining consent due to family or friends' objection
Number of subjects: 7112
Study 36175917 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) administered for 12 weeks, followed by an additional 12 weeks for all participants.
Number of subjects: 48
Study 36175917 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered for 12 weeks, followed by LDN for all participants.
Number of subjects: 48
Study 36175917 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN)
Number of subjects: 48
Study 33175114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive prehabilitation (tablet-based cognitive exercise targeting memory, speed, attention, flexibility, and problem-solving functions)
Number of subjects: 251
Study 33175114 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive prehabilitation)
Number of subjects: 251
Study 33383935 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized (1-1/e)-optimal algorithm
Number of subjects: 0
Study 33383935 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic (1-1/e)-approximation algorithm
Number of subjects: 0
Study 33383935 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic approximation algorithm with nearly ▵-1 approximation ratio
Number of subjects: 0
Study 36155955 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozex
Number of subjects: 32
Study 36155955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zip
Number of subjects: 32
Study 36155955 — intervention group
Group type: COMPARATOR
Intervention: Suture
Number of subjects: 32
Study 34243086 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with PM filter
Number of subjects: 39
Study 34243086 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with PM and VOCs filter
Number of subjects: 39
Study 34243086 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with sham filter
Number of subjects: 39
Study 34243086 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 mask
Number of subjects: 39
Study 34243086 — intervention group
Group type: COMPARATOR
Intervention: Sham mode (control)
Number of subjects: 39
Study 33592280 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic enteric-coated tablet containing diclofenac sodium
Number of subjects: 0
Study 33592280 — intervention group
Group type: COMPARATOR
Intervention: Control group (before domperidone administration)
Number of subjects: 0
Study 33930858 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Simulation (HS)
Number of subjects: 62
Study 33930858 — intervention group
Group type: COMPARATOR
Intervention: Low Fidelity Simulation (LFS)
Number of subjects: 62
Study 34253560 — intervention group
Group type: EXPERIMENTAL
Intervention: Fried meat consumption (4 times per week for 4 weeks)
Number of subjects: 117
Study 34253560 — intervention group
Group type: COMPARATOR
Intervention: Control group (restricted from fried meat intake for 4 weeks)
Number of subjects: 117
Study 34253560 — intervention group
Group type: EXPERIMENTAL
Intervention: Fried meat consumption
Number of subjects: 117
Study 33115524 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enhanced intervention using video visits for caregiver support and education during transitions.
Number of subjects: 0
Study 33115524 — intervention group
Group type: COMPARATOR
Intervention: Usual care practices (control group).
Number of subjects: 0
Study 35332771 — intervention group
Group type: EXPERIMENTAL
Intervention: Noble metal-alloy ETT (coated Bactiguard Infection Protection ETTs)
Number of subjects: 180
Study 35332771 — intervention group
Group type: COMPARATOR
Intervention: Standard non-coated ETT
Number of subjects: 180
Study 34375127 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use digital flexible ureteroscope (ZebraScope™)
Number of subjects: 49
Study 34375127 — intervention group
Group type: COMPARATOR
Intervention: Reusable flexible ureteroscope (URF-V)
Number of subjects: 49
Study 35685210 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed embryo transfer (FET)
Number of subjects: 424
Study 35685210 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression (MLR) model
Number of subjects: 424
Study 35685210 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical nomogram
Number of subjects: 424
Study 33742064 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval cycling followed by upper body resistance exercise (ER‐Arm)
Number of subjects: 8
Study 33742064 — intervention group
Group type: COMPARATOR
Intervention: Upper body resistance exercise only (R‐Arm)
Number of subjects: 8
Study 32264985 — intervention group
Group type: EXPERIMENTAL
Intervention: iMAPS therapy (six sessions of therapy using imagery techniques and imagery rescripting techniques)
Number of subjects: 5
Study 36210628 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidental (INC) irradiation
Number of subjects: 487
Study 36210628 — intervention group
Group type: COMPARATOR
Intervention: Intentional (INT) irradiation
Number of subjects: 487
Study 33279397 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy
Number of subjects: 34
Study 33279397 — intervention group
Group type: COMPARATOR
Intervention: Occlusal splints
Number of subjects: 34
Study 35474624 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4BN (internet-based cognitive-behavioral therapy)
Number of subjects: 149
Study 35474624 — intervention group
Group type: COMPARATOR
Intervention: CBTF2F (face-to-face cognitive-behavioral therapy)
Number of subjects: 149
Study 34114174 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 92
Study 34114174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 35275751 — intervention group
Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao acupuncture (AG)
Number of subjects: 20
Study 35275751 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 33989559 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks combined with cetuximab 400 mg/m2 intravenously (initial loading dose) followed by 250 mg/m2 intravenously weekly.
Number of subjects: 33
Study 33989559 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks combined with cetuximab 400 mg/m2 intravenously followed by 250 mg/m2 intravenously weekly.
Number of subjects: 33
Study 35434257 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-inflation group (balloon massaging with preliminary extracorporeal balloon inflation in saline water)
Number of subjects: 98
Study 35434257 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 98
Study 34705542 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g of FO n3 supplementation
Number of subjects: 20
Study 34705542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36314980 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative umbilicus preparation 30 minutes before surgery
Number of subjects: 400
Study 36314980 — intervention group
Group type: COMPARATOR
Intervention: No preoperative umbilicus preparation (control group)
Number of subjects: 400
Study 36314980 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups underwent TU-LESS surgery
Number of subjects: 400
Study 32028083 — intervention group
Group type: EXPERIMENTAL
Intervention: hydrocortisone
Number of subjects: 104
Study 32028083 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 104
Study 32028083 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine and hydrocortisone
Number of subjects: 104
Study 32028083 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 104
Study 34586628 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship education
Number of subjects: 1367
Study 33299400 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) plus physical therapy
Number of subjects: 80
Study 33299400 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline level of UE-FM
Number of subjects: 80
Study 33859386 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning predicted HER2-specific subset from computational library of trastuzumab variants (approximately 1 x 10^108 variants)
Number of subjects: 30
Study 33859386 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-sequenced libraries of trastuzumab variants (about 1 x 10^4 variants)
Number of subjects: 30
Study 32005066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR) pretreatment
Number of subjects: 50
Study 32005066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IVR pretreatment)
Number of subjects: 50
Study 35245011 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-rhGH 0.12 mg/kg/w
Number of subjects: 48
Study 35245011 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-rhGH 0.20 mg/kg/w
Number of subjects: 48
Study 35245011 — intervention group
Group type: COMPARATOR
Intervention: daily rhGH 0.28 mg/kg/w
Number of subjects: 48
Study 34634925 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet pretreatment
Number of subjects: 4881
Study 34634925 — intervention group
Group type: COMPARATOR
Intervention: No antiplatelet pretreatment
Number of subjects: 4881
Study 34634925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy
Number of subjects: 4881
Study 32746639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light (BWL) for 30 minutes daily for 8 weeks
Number of subjects: 51
Study 32746639 — intervention group
Group type: COMPARATOR
Intervention: Dim red light (DRL) for 30 minutes daily for 8 weeks
Number of subjects: 51
Study 32294620 — intervention group
Group type: COMPARATOR
Intervention: Control with intentional hydration (1 L of water the previous night, 500 mL 60 min before intervention, and 1 mL for each 1 g of body mass lost immediately after intervention)
Number of subjects: 18
Study 32294620 — intervention group
Group type: COMPARATOR
Intervention: Control without intentional hydration (ad libitum water ingestion before intervention)
Number of subjects: 18
Study 32294620 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with intentional hydration (cycle ergometer, 45 min, 50% of VO2peak)
Number of subjects: 18
Study 32294620 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise without intentional hydration
Number of subjects: 18
Study 35436934 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance Learning (DL)
Number of subjects: 118
Study 35436934 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (F-F)
Number of subjects: 118
Study 32053464 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions in school physical education, duration ranging from 5 min to 2 years.
Number of subjects: 71
Study 32053464 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental studies with randomized controlled trial design, specific interventions not detailed.
Number of subjects: 71
Study 32196413 — intervention group
Group type: EXPERIMENTAL
Intervention: General family social support
Number of subjects: 163
Study 32196413 — intervention group
Group type: EXPERIMENTAL
Intervention: General family social support and its subscales (information support, seeking support, instrumental support)
Number of subjects: 163
Study 36286665 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticosteroid hormones (GCS), specifically dexamethasone, used as an anti-inflammatory treatment for critically ill patients with COVID-19.
Number of subjects: 0
Study 36286665 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticosteroid hormones (GCS) in patients with COVID-19 outside critical conditions.
Number of subjects: 0
Study 32043343 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% HRmax
Number of subjects: 19
Study 32043343 — intervention group
Group type: COMPARATOR
Intervention: 60% HRmax
Number of subjects: 19
Study 32356505 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf massage
Number of subjects: 20
Study 32356505 — intervention group
Group type: COMPARATOR
Intervention: Control rest period (placebo)
Number of subjects: 20
Study 32311799 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 364
Study 32311799 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy regimens combined with trastuzumab
Number of subjects: 364
Study 36229177 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine + spectacles
Number of subjects: 164
Study 36229177 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-k + placebo
Number of subjects: 164
Study 36229177 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 164
Study 36229177 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops + spectacles (control)
Number of subjects: 164
Study 34871789 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized implementation support
Number of subjects: 1097
Study 34871789 — intervention group
Group type: COMPARATOR
Intervention: Group implementation support
Number of subjects: 1097
Study 33386634 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-guided dietary advice
Number of subjects: 84
Study 33386634 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 84
Study 35771366 — intervention group
Group type: EXPERIMENTAL
Intervention: mrTRG-directed management (intervention arm)
Number of subjects: 96
Study 35771366 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard management)
Number of subjects: 96
Study 33185927 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 20
Study 33185927 — intervention group
Group type: COMPARATOR
Intervention: Fractional Microneedling Radiofrequency (FMR)
Number of subjects: 20
Study 33142168 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic environment (37 °C)
Number of subjects: 21
Study 33142168 — intervention group
Group type: COMPARATOR
Intervention: Thermo-neutral environment (25 °C)
Number of subjects: 21